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duration of known diabetes was 6.80 ± 6.67 years. A substantial negative impact of 
diabetes on the participants’ HRQoL was observed as assessed by the ADDQoL (mean 
± SD average weighted impact (AWI) score: −3.76 ± 2.03 from the possible range −9 to 
+3), although the level of their TS was rather high as assessed by the DTSQs (mean ± 
SD TS scale total: 28.60 ± 5.53 out of 36). The participants’ EQ-5D scores (mean ± SD 
EQ-utility score: 0.74 ± 0.20; EQ-VAS score: 65.22 ± 17.54) were only slightly lower 
than the norm values for the general population (0.80 ± 0.26 and 79.74 ± 18.23 for the 
two scores, respectively). Higher income was signiﬁ cantly associated with better health 
status while lower education and unemployment status were signiﬁ cantly associated with 
poorer HRQoL. Female gender and older age were associated with higher TS. CON-
CLUSIONS: Diabetes had major impact on the participants’ HRQoL but little impact 
on health status despite a high level of TS. Patient characteristics associated with these 
outcomes were also different. 
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OBJECTIVES: To develop a Thai version of the Audit of Diabetes-Dependent Quality 
of Life (ADDQoL-19) and to evaluate its psychometric properties among Thai patients 
with diabetes. METHODS: This study was conducted by ﬁ rstly cross-culturally adapt-
ing the original English ADDQoL-19 into Thai, followed by administering the Thai 
version together with the Thai EQ-5D and sociodemographic questionnaire to patients 
(aged >18 years) with diabetes recruited from a tertiary hospital in central Thailand 
by simple random sampling. The usefulness of a ‘not applicable’ (N/A) option and the 
necessary of weighting the impact scores, factor structure and internal consistency 
reliability of the Thai ADDQoL-19 were assessed. Data were subjected to conﬁ rma-
tory factor analysis (CFA) using structural equation modeling (SEM) and exploratory 
factor analysis (EFA) using principal component analysis (PCA). The known-groups 
validity of the Thai ADDQoL was assessed by four a priori hypotheses. RESULTS: 
The Thai ADDQoL-19 was shown to be conceptually equivalent to its original version 
and culturally relevant to Thai patients with diabetes. Its psychometric properties were 
evaluated among 201 diabetic patients (71.1% females; 81.6% primary educated; 
mean age 54.25 [SD = 9.8] years). Its unique characteristics, i.e., weighting and indi-
vidualization were proved to be necessary for a more accurate assessment of quality 
of life. The Thai ADDQoL-19 also demonstrated a good internal consistency reli-
ability, with the Cronbach’s alpha of 0.90. However, the ﬁ t indices derived from a 
CFA failed to achieve a good ﬁ t (i.e., >0.90). EFA with forced-one factor solution 
showed factor loadings above 0.40 for all items, except for sexual relationship. The 
known-groups validity was also not clear as only two hypotheses were fully fulﬁ lled. 
CONCLUSIONS: The Thai ADDQoL-19 has shown to be culturally appropriate and 
highly reliable but requires further investigations to provide more evidence on its 
factor structure and known-groups validity before its utilization in routine clinical 
settings. 
PDB17
EVALUATING THE CHOICE OF PEN VERSUS SYRINGE: IMPLICATIONS 
FOR LONG-TERM DIABETES MANAGEMENT
Brod M1, Thomsen TL2, Christensen T2
1The Brod Group, Mill Valley, CA, USA; 2Novo Nordisk A/S, Virum, Denmark
OBJECTIVES: The two most commonly used insulin delivery devices, pens and 
syringes, have comparable safety proﬁ les and efﬁ cacy under similar use conditions. 
Therefore, the decision regarding the preferred device must be based on other consid-
erations such as treatment satisfaction, treatment adherence, health-related quality of 
life (HRQoL), health-care expenditure and utilization. METHODS: A literature search 
was conducted of published articles in peer reviewed journals listed in the US National 
Library of Medicine’s PubMed (1948–present), DIALOG including PsychInfo (1887–
present), EMCARE (nursing lit., 1995–present), BIOSIS (1993–present), EMBASE 
(Excerpta Medica, 1974–present), SciSearch (1990–present) and MEDLINE. Relevant 
manuscripts were classiﬁ ed into subcategories based on the major focus of the article 
reviewed and then subcategories were collapsed into major categories: treatment 
satisfaction, treatment adherence, HRQoL, and health-care expenditure and utiliza-
tion. RESULTS: A total of 135 publications were reviewed for inclusion of which 73 
manuscripts and nine conference abstracts/poster were deemed relevant and reviewed 
in depth. Seventeen reported ﬁ ndings from clinical trials and 13 were review articles. 
There is substantial evidence demonstrating the superior beneﬁ ts of pens over syringes. 
Treatment satisfaction and patient preference for pens over syringes was widely 
reported and patients reported that pens provided them with increased conﬁ dence in 
dose, ability to self-inject, superior convenience and overall ease of use. Pen users 
reported better treatment adherence and fewer missed insulin doses which may 
account for the reported better HbA1c control than with syringe. Health-care expen-
diture and utilization were higher in the short term for pens; however, these expendi-
tures were minor in comparison with long-term savings that result from improved 
decreases in hospitalizations, incidence of side effects, physician visits and emergency 
department visits. CONCLUSIONS: Long- and short-term diabetes management 
should beneﬁ t from the choice of pen as the insulin delivery method based on PRO 
outcomes and long term cost effectiveness. 
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OBJECTIVES: As diabetes rates rise, it is important to understand the proﬁ le of those 
who are at-risk for developing diabetes but have not yet been diagnosed. The aim of 
this study was to assess the burden for these high-risk patients. METHODS: The 
current study used US 2009, EU 2008, and Japan 2008 datasets from the National 
Health and Wellness Survey (NHWS). Implementing a previously-developed algo-
rithm, all patients not diagnosed with diabetes were classiﬁ ed as having or not having 
a high risk for developing diabetes. High-risk patients were compared with controls 
on health-related quality of life (physical component summary (PCS) scores of the 
SF-12v2) and the number of emergency room (ER) visits controlling for demographics 
(country, age, gender, ethnicity, income, education) and patient characteristics (BMI 
and Charlson comorbidity index). RESULTS: Of patients not diagnosed with diabetes, 
16.64% (n = 10778) in the United States, 14.33% (n = 7481) in the EU, and 4.05% 
(n = 750) in Japan were classiﬁ ed as being at high risk for diabetes. After controlling 
for demographics and patient characteristics, those at high risk reported signiﬁ cantly 
lower levels of PCS across all three countries (Adjusted Mean [Madj] = 46.2 vs. 49.6, 
P < 0.0001) than controls. The effect was stronger in the EU (M-adj = 45.5 vs. M-adj 
= 49.2) and weaker in Japan (M-adj = 47.9 vs. M-adj = 49.8) relative to the United 
States (M-adj = 46.6 vs. M-adj = 49.7). Those at high risk reported signiﬁ cantly fewer 
ER visits (Madj = 0.12 vs. M-adj = 0.16, P < 0.0001) than controls, however, this effect 
was reversed in Japan in that those at high risk reported signiﬁ cantly more ER visits 
than controls (M-adj = 0.21 vs. M-adj = 0.12, P < 0.0001). CONCLUSIONS: A sub-
stantial number of patients are at a high risk for developing diabetes, particularly in 
the United States and EU. The physical quality of life was signiﬁ cantly lower, particu-
larly in the EU and the United States, and in Japan this group reported signiﬁ cantly 
more ER visits than controls. 
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OBJECTIVES: Diabetes Mellitus (DM) can reduce patients’ physical well-being and 
compromise other aspects of quality of life. This study aims to investigate the health-
related quality of life (HRQoL) of DM patients under primary care, and the associa-
tions of HRQoL with demographic factors and HbA1c control. Previous studies that 
examined these associations yielded mixed results and none was done in Singapore. 
METHODS: A cross-sectional, interviewer-administered survey was conducted in 
either English or Chinese, depending on the patient’s language of preference, between 
September and December 2009 in a convenience sample of 301 DM patients who 
were ≥21 years old, on hypoglycemic agent(s), with at least a year of DM history, and 
followed up at two outpatient clinics. Survey instrument included demographic ques-
tions and one generic and one DM-speciﬁ c HRQoL measures, i.e., EQ-5D and the 
Audit of Diabetes-Dependent Quality of Life (ADDQoL), respectively. Patients’ most 
recent HbA1c values were extracted from medical records in the clinics. RESULTS: 
The average EQ-5D score was 0.89 ± 0.16 and ADDQoL average weighted impact 
(AWI) score was −2.5 ± 2.0. Pain was the most common complaint among the ﬁ ve 
EQ-5D domains (by 28% of the respondents). Lack of freedom to eat was the 
ADDQoL domain with the greatest negative impact (AWI = −3.8, on a scale of −9 to 
3). A signiﬁ cant association was observed between ADDQoL AWI and both duration 
of diabetes (P = 0.005) and use of insulin (P = 0.014). A negative correlation was 
found between HRQoL and HbA1c values in both HRQoL measures (both r = −0.2, 
P < 0.01). CONCLUSIONS: DM patients in primary care settings frequently reported 
problems with pain and restrictions in diet. Poorer HRQoL was found to be associated 
with higher HbA1c, which indicates poorer glycemic control. The chronicity of DM 
and use of insulin may have negative impact on patients’ HRQoL. 
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OBJECTIVES: To examine the association between patterns of cardiovascular medica-
tion use and health-related quality of life (HRQoL) in elderly Australian women with 
diabetes. METHODS: A cross-sectional study was conducted using older cohort com-
pleting Survey 4 in the Australian Longitudinal Study on Women’s Health (ALSWH) 
who self-reported to have been diagnosed with diabetes and/or use medications indica-
tive of diabetes. Use of cardiovascular medications was identiﬁ ed from self-reported 
medications belonging to the Anatomical Therapeutic Chemical (ATC) code B01AC, 
C03, C07, C08, C09, C02 and C10. Usage patterns were classiﬁ ed as no use, using any 
hypertensives, lipid lowering agents or antiplatelet drugs, using any two classes, and 
using all the three classes. The SF-36 was used to measure HRQoL, focusing on the 
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physical functioning (PF), general health (GH), vitality (VT) and mental health (MH) 
subscales. Multiple linear regressions were used to assess the association between usage 
patterns, HRQoL scores and other sociodemographic, health behavior and health service 
utilization characteristics. RESULTS: Of 7158 women retained at Survey 4, 885 were 
identiﬁ ed as having diabetes with overall prevalence of cardiovascular medication use 
of 89.9%. After adjusting for other covariates, being on three classes of cardiovascular 
medications was signiﬁ cantly associated with increased scores on PF (coefﬁ cient 16.134, 
95% CI 6.940–25.327), GH (10.058, 95% CI 2.649–17.468) and MH (12.896, 95% 
CI 6.562–15.882) subscales. Being on any two classes was associated with increased 
scores on PF and GH (coefﬁ cient 14.744, 95% CI 5.988–23.501 and 8.334, 95% CI 
1.200–15.467, respectively), whereas using single cardiovascular drug was only signiﬁ -
cantly associated with increased scores on PF (coefﬁ cient 12.346, 95% CI 3.943–
20.750). CONCLUSIONS: Intensive use of cardiovasular medications to support 
diabetes management was shown to be subjectively beneﬁ cial. Concern about perceived 
deterioration on HRQoL attributable to pill burden might be captured if a diabetes-
speciﬁ c instrument was employed. 
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OBJECTIVES: CBIA is a small group discussion which emphasizes on the active role 
of participants in looking for information. CBIA has been proven effective to improve 
tuberculosis patient’s adherence to treatment program, pharmacy assistant’s skills in 
hypertension drug information service, and skills in early detection of Brest cancer. 
Therefore, CBIA was developed adapting the original CBIA, enriched with key mes-
sages in healthy life-style for diabetic patients as CBIA-DM. This study was aimed to 
assess the impact of CBIA-DM on diabetic patients’ quality of life. METHODS: Time 
series, pre and post quasi-experimental design. Three groups were involved in the 
study: CBIA-DM, DM-club and normal-care group. Data were collected in pre-
intervention, immediately, one, three and 6 months post intervention using WHO-
QOL-bref questionnaires Bahasa version. Categorizing scores in good (>mean + SD), 
fair (between mean + SD and mean − SD), and poor (<mean − SD) level. Effectiveness 
of CBIA-DM was assessed based on the increasing of participant number in good level 
which steady remains until 6 months post-intervention, time-required and cost/person 
for conducting CBIA-DM, and acceptance of CBIA-DM by the participants. RESULTS: 
In general quality of life, participant number of CBIA-DM (n = 30) increased from 
13.3% to 16.7%. In health status: general, physical, psychological, social-relation-
ships, and environment, increased from 23.3% to 40%, 13.3% to 23.3%, 16.7% to 
23.3%, 16.7% to 30%, and 16.7% to 26.7% respectively. Time-required for conduct-
ing CBIA-DM was one-third (3 vs. 9 hours) with cost/person 0.28 (US D 6.50 vs 
22.75) compared to DM-club. Participants expressed that CBIA-DM was enjoyable. 
CONCLUSIONS: CBIA-DM is cost effective strategy and has positive-impact on 
diabetic patients’ quality of life. 
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OBJECTIVES: To assess utilization and prescribing patterns of antidiabetics in 
Taiwan. METHODS: This cross-sectional study used the Taiwanese Diabetic Pay-for-
performance Register to extract a diabetic outpatient claim dataset from the National 
Health Insurance reimbursement data. Adult diabetic patients with at least one antidia-
betic prescription during 2004 to 2008 were indentiﬁ ed and prescription details were 
collected. Antidiabetic drugs were stratiﬁ ed by into injection (insulin) and ﬁ ve chemical 
groups of oral drugs. Pattern of antidiabetic combination was categorized by both type 
and number of combined drugs. Frequency of different prescribing pattern was calcu-
lated and presented as annual prescribing rate and analyzed by Cochran-Armitage trend 
test to test a signiﬁ cant ascending or descending trends. All data was processed in SAS 
9.1. 3. RESULTS: Over 95% prescribing patterns was composed of monotherapy, 
combination of any two, and combination of any three antidiabetics with approximate 
30%, 47%, and 18% annual prescription rate, respectively. The most frequent types 
of drugs within above three patterns included single sulfonylurea (SU1), combined one 
biguanide and one sulfonylurea (BG1+SU1), and combined one biguanide, one sulfo-
nylurea and one thiazolidinedione (BG1 + SU1 + TZD1). Prescribing rates of SU1 
(from 18.1% to 9.83%) and BG1 + SU1 (from 37.6% to 34.46%) decreased over the 
study period (P < 0.001), but BG1 + SU1 + TZD1 revealed an increasing trend (from 
8.45% to 10.99%, P < 0.001). Any prescribing pattern containing insulin presented 
an incremental annual prescribing rate, but the prescribing rates for those only con-
sisted of oral antidiabetics declined over time. CONCLUSIONS: Antidiabetic prescrib-
ing patterns in Taiwan have changed and shifted from simple monotherapy to multiple 
combinations of newer drugs. Meanwhile, prescribing rates of single-use or combine-
use insulin have also risen. It is necessary to further investigate the impacts of change 
prescription patterns on diabetic complications. 
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OBJECTIVES: Diabetes has become one of the major chronic diseases of the 21st 
century, and has ranked ﬁ fth on the main causes of death in Taiwan for years. The 
high cost of antidiabetic medications expenditure has brought the concern on 
the generic and brand drugs substitution. The purpose of the study was to investigate 
the effects of hospital drug brands changes on physicians’ prescription behavior and 
patients’ outcomes. METHODS: The study was conducted at a medical center in 
Taipei city. We recruited those who had taken the same medicine regularly from 
January 2004 to June 2004. In the next 4 years, the study hospital had changed the 
manufactures of metformin four times. Physicians’ prescription data and patients’ 
glycated hemoglobin values were collected. We retrospectively analyzed the prescrip-
tion patterns for oral antidiabetes medications of patients with persistence medication 
service in ﬁ ve different metformin brand stages. RESULTS: The results show 1) the 
average item of anti-diabetes drugs in each prescription was signiﬁ cantly increased; 2) 
the prescription rates were signiﬁ cant increased for acarbose and insulin, and decreased 
for metformin, glibenclamide and rosiglitazone; 3) The daily dose of metformin, which 
was on average between 1565 mg and 1611 mg, wasn’t increased signiﬁ cantly regard-
less of the change in manufacturers; and 4) The HbA1c values of study patients were 
increasing, but no signiﬁ cant difference was observed in different metformin brand 
stages. CONCLUSIONS: The use of generic drugs can effectively reduce the cost of 
medication. The results provide information for hospital administrators in drug pur-
chasing and price negotiating with the manufacturers. 
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OBJECTIVES: To study the transition time of patients with Type 2 diabetes mellitus 
(T2DM) progressing from “good” to “poor” glycemic control and its association with 
the number and type of diabetes-related vascular diseases such as coronary heart 
disease, stroke, eye complications, peripheral vascular disease, and nephropathy. 
METHODS: In this retrospective study, data from a disease registry were used. A 
cohort of T2DM patients who had attended either a hospital specialist clinic or a 
primary care diabetes service, and deemed to have “good” control (at least two 
consecutive HbA1c ≤ 7%) from October 2005 to March 2006 were included in this 
study. Patients were subsequently followed up for a period of 4 years. Time to “poor” 
glycemic control (HbA1c > 8%) for each diabetes-related vascular disease was calcu-
lated using Kaplan–Meier analysis. Hazards Ratio (HR) was adjusted for age, gender, 
ethnicity, BMI, duration of diabetes, baseline HbA1c, LDL-cholesterol and insulin use 
using Multivariate Cox analysis. RESULTS: There were 7739 T2DM patients, with 
median age of 68 years and baseline HbA1c of 6.4%. Over a quarter (28.9%) of 
patients reached “poor” control at the end of 4 years, with a median time of 575 days 
(95% CI: 550–600). Multivariate Cox regression analysis suggested that likelihood of 
“poor” control was increased with each additional diabetes-related vascular disease 
(AdjHR 1.14, 95% CI: 1.07–1.23) and higher for eye complications (AdjHR 1.47, 
95%CI: 1.17–1.86) and nephropathy (AdjHR 1.43, 95% CI:1.06–1.93). CONCLU-
SIONS: Despite starting with “good” glycemic control, 3 out of 10 T2DM patients 
progressed to “poor” glycemic control at the end of 4 years of study. Patients with 
more diabetes-related vascular diseases were at higher risk of progressing to “poor” 
control, particularly those with microvascular complications. 
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OBJECTIVES: Type 2 diabetes mellitus (T2DM) patients often have co-existing hyper-
tension and dyslipidemia and some develop retinopathy, peripheral vascular disease 
(PVD), stroke, nephropathy and coronary heart disease (CAD). This study investigates 
the prevalence of these conditions which are associated with T2DM and the associa-
tion with optimal glycemic control (HbA1c up to 7%). METHODS: This is a cross-
sectional study. We included all T2DM patients who were treated at the specialist 
outpatient clinics (SOCs) in three public-sector hospitals in Singapore during January 
2009 and were on follow-up at the same clinic for at least 12 months. All data were 
extracted from the National Healthcare Group (NHG) Diabetes Registry (CDMS), 
including the medical diagnosis and HbA1c result at the last visit. We compared the 
distribution of glycemic control for each diabetes-related condition and performed 
logistic regression for “optimal” glycemic control adjusting for age, gender and ethnic-
ity. RESULTS: Of the 3420 T2DM patients, 2919 (85%) with HbA1c results were 
analyzed. Mean age was 63.2 years, with 53% female and 66% Chinese, high preva-
lence of dyslipidemia (92.7%) and hypertension (74.5%). About 1249 (42.8%) 
patients had “optimal” glycemic control. CAD (28.7%) was the most common condi-
tion, followed by PVD (22.5%), retinopathy (21.8%), nephropathy (14.4%) and 
stroke (10.7%). The Malay group had the highest proportion of hypertension 
